Lanfear Dennis M has filed 11 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 750000 shares of Coherus Oncology, Inc. ($CHRS) on January 23, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 116,229,170 | 9999.99% | 0.65% |
| Jan. 23, 2026 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | A | Common Stock | 375000 | $0.00 | 1,567,884.0000 | 116,229,170 | 31.44% | 0.32% |
| Jan. 20, 2026 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | F | Common Stock | 11839 | $1.55 | 1,192,884.0000 | 116,229,170 | 0.98% | 0.01% |
| May 7, 2025 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | A | Stock Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 115,857,780 | 9999.99% | 0.32% |
| Jan. 20, 2025 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | F | Common Stock | 11810 | $1.39 | 1,204,723.0000 | 114,553,537 | 0.97% | 0.01% |
| Jan. 10, 2025 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | A | Stock Option (Right to Buy) | 575000 | $0.00 | 575,000.0000 | 114,553,537 | 9999.99% | 0.50% |
| Jan. 4, 2025 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | F | Common Stock | 11810 | $1.66 | 1,216,533.0000 | 114,553,537 | 0.96% | 0.01% |
| July 22, 2024 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | A | Stock Option (Right to Buy) | 196500 | $0.00 | 196,500.0000 | 114,819,965 | 9999.99% | 0.17% |
| Jan. 20, 2024 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | F | Common Stock | 11218 | $2.44 | 1,228,343.0000 | 94,162,637 | 0.90% | 0.01% |
| Jan. 5, 2024 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | A | Stock Option (Right to Buy) | 575000 | $0.00 | 575,000.0000 | 94,162,637 | 9999.99% | 0.61% |
| Jan. 4, 2024 | Coherus Oncology, Inc. | $CHRS | Lanfear Dennis M | President & CEO | F | Common Stock | 11781 | $2.92 | 1,239,561.0000 | 94,162,637 | 0.94% | 0.01% |